-
The Innovations in SLD Think-Tank 2024 has been granted 7.0 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical
Education (EACCME®). -
It is a pleasure to announce that the confirmed venue for the Think-Tank is at the following location: Círculo Ecuestre: Balmes, 169 Bis - 08006 Barcelona - Spain
-
It is a pleasure to announce that the confirmed venue for the NIT Summit is at the following location: Catalonia Diagonal Centro Hotel Barcelona: C/ de Balmes, 142, 146, Eixample - 08008 Barcelona - Spain
-
To stay updated on the latest developments, make sure you are signed up for our newsletter.
Topics
Meeting category
Date(s)
3 May 2024 - 4 May 2024
Location
Barcelona,
Spain
Meeting type
In-Person Meeting
CME Credits
7
Organizer
Innovations in SLD Think-Tank 2024
General
What's New
Welcome from the Program Chairs
Innovations in SLD Think-Tank: Industry, practitioners and patient advocates translating science into diagnoses, prevention, treatments, and policy.
During this two-day intensive, our five roundtables will focus on key areas emphasized in the recent global consensus on research and action priorities:
1. Bridging the Diagnostics Gap:
SLD is experiencing cutting-edge advances for testing, accelerated uses for artificial intelligence, and fully scalable industrial solutions for diagnostics. Yet a chasm between increasing prevalence and diagnoses persists.
- At Innovations we will intensively focus together on bridge-building to cross this diagnosis chasm.
2. Prevention is the ‘Cure’ Hidden in Plain Sight:
The socio-economic burden of SLD is growing almost unabated. Yet metabolic dysfunction can be addressed through prevention. Translating clinical evidence into real-world practice and sustaining patient health outcomes remains a steadfast challenge.
- At Innovations we will ideate next-generation solutions to reinvigorate prevention in the public health policy and SLD practice.
3. The Future of Treatments Now:
Hard-fought, not-yet-won MASH pharmacological therapeutics may yet be approved by regulators later this year. Moreover, evidence-based lifestyle interventions remain crucial with - and especially without - drug approvals for patient treatment and care.
- At Innovations industry, practitioners and patient-advocates will hammer-out immediately actionable steps for what we anticipate being a rapidly evolving treatments landscape for SLD patients, particularly MASH patients.
4. Making Ready Our World Unready:
Comorbidity is “growing younger,” yet global policy still ‘thinks’ of non-communicable disease co-morbidities as a condition of aging. We rapidly approach a world in which 1 in 10 people by the age of 18 will present with at least two metabolic associated-dysfunction comorbidities. While policy recognizes diseases and conditions like diabetes, obesity, and hypertension, SLD is under-addressed and in many cases completely absent from public health policy and health systems preparedness.
- At Innovations industry, practitioners and patient-advocates will discern together both policy-oriented recommendations (e.g., reflect SLD) and operationally necessary actions (e.g., grow the SLD community of practice) to prepare the world, especially health systems, for this growing reality.
5. Targeting Investments for Social and Economic Returns:
2030 fast approaches. Will history report that the Sustainable Development Goals were merely aspirational? Or might the record reflect that a ‘dedicated few’ boldly stepped-forward to path-find targeted choices and scalable paths for the many?
- At Innovations we will roll-up our sleeves, pull-out our compasses, illustrate best-buy choices and chart paths – some obvious, others unconventional.
Join us in Barcelona. Be the change.
Remember to bring your dancing shoes!
Program Chairs
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the Innovations in SLD Think-Tank 2024 will be held as an in-person meeting.
We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Dominika Balounova via Dominika.balounova@amededu.com.
We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Dominika Balounova via Dominika.balounova@amededu.com.
Who Should Attend
- Hepatologists
- Diabetologists
- Endocrinologists
- Obesity experts
- Internal medicine specialists
- Gastroenterologists
- Primary care physicians
- Dieticians
- Nurses
- Physiotherapists
- Policymakers
- Public health officials
- Patient advocates
- Diabetologists
- Endocrinologists
- Obesity experts
- Internal medicine specialists
- Gastroenterologists
- Primary care physicians
- Dieticians
- Nurses
- Physiotherapists
- Policymakers
- Public health officials
- Patient advocates
Meeting Objectives
The meeting aims to:
- Gather patients and leading experts from different disciplines involved in MASLD care;
- Share the knowledge that exists in different fields and healthcare facilities; and
- Raise awareness and support the implementation of multidisciplinary management of MASLD.
- Gather patients and leading experts from different disciplines involved in MASLD care;
- Share the knowledge that exists in different fields and healthcare facilities; and
- Raise awareness and support the implementation of multidisciplinary management of MASLD.
Learning Objectives
After participating in this meeting, participants will be able to:
- Define the epidemiology of MASLD and its interplay with other cardio-metabolic complications;
- Describe clinical care pathways for the risk stratification and management of MASLD patients;
- Evaluate weight management in patients with MASLD;
- Reflect on the implementation of comprehensive models of care for MASLD/NASH; and
- Classify pharmacotherapeutics used for obesity, diabetes, and those in the pipeline for NASH.
- Define the epidemiology of MASLD and its interplay with other cardio-metabolic complications;
- Describe clinical care pathways for the risk stratification and management of MASLD patients;
- Evaluate weight management in patients with MASLD;
- Reflect on the implementation of comprehensive models of care for MASLD/NASH; and
- Classify pharmacotherapeutics used for obesity, diabetes, and those in the pipeline for NASH.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the meeting is English.
Translation will not be provided.
Translation will not be provided.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the meeting.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Academic Medical Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Academic Medical Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the meeting participants agree that the organizers do not accept responsibility for medical, travel or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Think-Tank Program
Innovations in SLD Think-Tank
Think-Tank program: <definition>
Think tanks are organized to generate ideas and provide insights and recommendations on various subjects, such as policy, economics, technology, social issues, or international relations.
Overall, think-tank programs play a crucial role in contributing to informed decision-making, shaping public discourse, and addressing complex challenges by providing evidence-based research and policy recommendations. These programs are often associated with intellectual rigor, interdisciplinary collaboration, and a commitment to advancing knowledge in their respective fields.
-
It is a pleasure to announce that the confirmed venue for the Think-Tank is at the following location:
Balmes, 169 Bis
08006 Barcelona
Spain
Distance from Josep Tarradellas Barcelona-El Prat Airport: 16.2 km (22 minutes)
Day 1 - Friday, 3 May 2024
Opening of the Think-Tank - 2.00
Jeffrey Lazarus, PhD, MIH, MA
2.00 PM
Opening of the Meeting by Program Chairs
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Session 1: Bridging the Diagnostics Gap -
Prof. Pere Ginès, MD, PhD
Moderators
2.10 PM
Introduction of the Topic
2.20 PM
Panel Members - Discussion
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona (Catalonia, Spain)
2.40 PM
Faculty - Discussion
3.30 PM
Audience - Discussion
3.20 PM
Conclusion / Take Home Message
3.30 PM
Coffee Break & Networking
Session 2: Prevention is the ‘Cure’ Hidden in Plain Sight -
Paul N. Brennan, B.Sc(Hons), MRes, MB ChB, MRCP(UK), MRCP(Edin)
Moderators
4.00 PM
Introduction of the Topic
4.10 PM
Panel Members - Discussion
University of Dundee, United Kingdom
4.30 PM
Faculty - Discussion
4.50 PM
Audience - Discussion
5.10 PM
Conclusion / Take Home Message
Social Media in MASLD Education - 5.20
5.20 PM
Discussion
5.50 PM
Poster Viewing | Early-Career Investigators
7.30 PM
Think-Tank Informal Dinner
Day 2 - Saturday, 4 May 2024
Session 3: The Future of Treatments Now -
Jeffrey Lazarus, PhD, MIH, MA
Alia Hadefi, MD, PhD student
Didac Mauricio, MD, PhD
Moderators
9:45
Welcome by Program Directors
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
10.00 AM
Introduction of the Topic
10.10 AM
Panel Members - Discussion
CUB Hôpital Erasme, Hôpital Universitaire de Bruxelles, Brussels, Belgium
Hospital de la Santa Creu i Sant Pau CIBERDEM/University of Vic & Central University of Catalonia, Spain
10.30 AM
Faculty - Discussion
10.50 AM
Audience - Discussion
11.10 AM
Conclusion / Take home message
Open Space Science in MASLD - 11.20
11.20 AM
Open Space Science in MASLD
12.20 PM
Lunch
Session 4: Making Ready Our World Unready -
Núria Alonso, MD, PhD
Jeffrey Lazarus, PhD, MIH, MA
Scott Isaacs, MD, FACP, FACE
Moderators
1.30 PM
Introduction of the Topic
1.40 PM
Panel Members - Discussion
Germans Trias i Pujol Hospital in Badalona, Barcelona, Spain / Autonomous University of Barcelona (UAB), Spain
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Emory University School of Medicine; American Association of Clinical Endocrinology, United States
2.00 PM
Faculty - Discussion
2.20 PM
Audience - Discussion
2.40 PM
Conclusion / Take Home Message
2.50 PM
Coffee Break & Networking
Session 5: The Global Economics of MASLD - Supported by the Global NASH Council -
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
Mário Guimarães Pessoa, MD, PhD
Moderators
Beatty Liver and Obesity Research, Inova Health System, United States
3.15 PM
Introduction of the Topic
Beatty Liver and Obesity Research, Inova Health System, United States
3.25 PM
Panel Members - Discussion
Division of Gastroenterology and Hepatology University of São Paulo School of Medicine, Brazil
3.45 PM
Faculty - Discussion
4.05 PM
Audience - Discussion
4.25 PM
Conclusion / Take Home Message
Closing Words by the Chairs - 4.35
Jeffrey Lazarus, PhD, MIH, MA
4.35 PM
Summary of the Key Messages
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
4.45 PM
End of Think-Tank
NIT Summit
Venue
-
It is a pleasure to announce that the confirmed venue for the NIT Summit is at the following location:
Catalonia Diagonal Centro Hotel Barcelona
C/ de Balmes, 142, 146, Eixample
08008 Barcelona
Spain
Distance from Josep Tarradellas Barcelona-El Prat Airport: 16.5 km (25 minutes)
Program
All times are in Central European Summer Time (CEST). If you would like another time zone, this might be of use to you: https://www.worldtimebuddy.com/
About
The MASH-NITs Real-World-Evidence Summit is a two-hour in-person summit, where ample time is reserved for plenary talks, case based-presentations, practical sessions and discussion to exchange knowledge and reinforce the implementation of real-world evidence for the screening, identification, and diagnosis of MASLD/MASH.
The summit will be hosted in Barcelona on 3 May as a pre-workshop to the 3rd edition of the Innovations in SLD Think-Tank. The overarching goal of the MASH-NITs Real-World-Evidence Summit is to promote a
heterogeneous use of NITs using real-world data to accelerate the identification of undiagnosed patients and the risk factors for developing MASLD and MASH. Enduring materials will be posted on the AME online platform, and will be publicly accessible on-demand to further support knowledge retention and increase the educational impact.
Day 1 - Friday, 3 May 2023
Opening - 10:30
Jeffrey Lazarus, PhD, MIH, MA
Jeffrey Lazarus, PhD, MIH, MA
10:30 AM
Opening of the NIT Summit by Program Chairs
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Organizers
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Session 1: NIT overview for Non-NIT Specialists - 10:40
Prof. Pere Ginès, MD, PhD
Didac Mauricio, MD, PhD
10:40 AM
NITs - Lessons from LIVER Screen and LIVERAIM
Liver Unit, Hospital Clinic, University of Barcelona, Barcelona (Catalonia, Spain)
10:50 AM
Blood-Based Biomarkers for Diagnosis and Prognosis: Advantages and Pitfalls
11:00 AM
Imaging Biomarkers for Diagnosis and Prognosis: Advantages and Pitfalls
11:10 AM
MASLD Identification and Risk Stratification: From Guidelines to Successful Clinical Care Pathways
11.20 AM
Discussion
Hospital de la Santa Creu i Sant Pau CIBERDEM/University of Vic & Central University of Catalonia, Spain
11.30 AM
Coffee Break & Networking
Session 2: Deep Dive into NIT Methods - 11:50
11:50 AM
Review Emerging Biomarkers (AI, Omics, Microbiome, New Elastography Techniques)
12:05 PM
What Do I Do in the Liver Clinic When NITs are Discordant?
12:20 PM
Discussions & Practical Sessions
1:00 PM
End of NIT Summit
Registration
Registration is Open!
Fees and Conditions
|
Regular Delegates - |
|
|---|---|
|
Early Fee (payment before/on 3 October 2023) |
€495.00 |
|
Standard Fee (payment before/on 19 April 2024) |
€695.00 |
|
Onsite/Same Day Fee (payment on/after 20 April 2024) |
€795.00 |
|
Discounts |
|
|---|---|
|
Early-career investigators and/or academia from Resource-Limited Settings (RLS)**, NGO representatives, government representatives, and community advocates |
50% Off Current Regular Delegates Fee |
|
Early-career investigators and/or academia from Resource-Limited Settings (RLS)** WITH ACCEPTED ABSTRACT |
100% Discount |
|
Representatives of sponsoring industry / endorsing organizations |
Please contact the conference secretariat |
|
People living with steatotic liver disease |
100% Off Current Regular Delegates Fee |
** Countries included in the low-income and lower-middle-income economies of the World Bank Classification.
If you have financial concerns or are eligible for a discount, please contact the conference secretariat via Dominika.balounova@amededu.com
Important
-
AME (Academic Medical Education) reserves the right to cancel improper registrations. Claims for a refund will not be honored.
-
We strongly advise that you register early to ensure your registration.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
Cancellation Policy
In case of cancellation, the following refunds are applicable:
- Cancellation before/on 2 April 2024: 50% refund (minus an administration fee of €40)
- Cancellation after 3 April 2024: Unfortunately, no refund will be given
If you are unable to attend the meeting a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 19 April 2024. A statement (email/letter) of cancellation must be sent to AME.
- Cancellation before/on 2 April 2024: 50% refund (minus an administration fee of €40)
- Cancellation after 3 April 2024: Unfortunately, no refund will be given
If you are unable to attend the meeting a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 19 April 2024. A statement (email/letter) of cancellation must be sent to AME.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer complimentary registration to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the registration fee without an accepted abstract.
IMPORTANT: Complimentary registration is offered to the presenting author only.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Academic Medical Education secretariat at least two weeks prior to the start of the workshop. Academic Medical Education will contact the early-career investigator with instructions regarding the registration procedure.
IMPORTANT: Complimentary registration is offered to the presenting author only.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Academic Medical Education secretariat at least two weeks prior to the start of the workshop. Academic Medical Education will contact the early-career investigator with instructions regarding the registration procedure.
Group Registration
For registration of groups larger than 5 participants, please contact Dominika Balounova at Dominika.balounova@amededu.com to use the Group Registration Portal.
Payment
By credit card only: online or by written authorization (see online registration).
Please contact the conference secretariat via Dominika.balounova@amededu.com if you need to make alternative arrangements.
Please contact the conference secretariat via Dominika.balounova@amededu.com if you need to make alternative arrangements.
Registration Fee Includes
- Access to all scientific sessions
- Access to enduring materials
- Workshop materials
- Access to enduring materials
- Workshop materials
Sponsored Attendance
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A fee waiver may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A fee waiver may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this meeting, Academic Medical Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Academic Medical Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting. In case of cancellation of the meeting due to unforeseen circumstances, Academic Medical Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Abstracts
The abstract submission portal for Innovations in SLD Think-Tank 2024 is closed.
Abstracts
-
The deadline for abstract(s) submission for Innovations in SLD Think-Tank 2024 has passed.
- SLD Care Think-Tank 2024 accepted new original data as well as encored abstracts. All abstracts must have focused on healthcare challenges related to MASLD Care and contain up-to-date information at the time of the meeting.
- Registration fees were waived for healthcare professionals from RLS and early-career professionals with an accepted abstract. A 50% discount was offered to healthcare professionals from RLS and early-career professionals without an accepted abstract. The requirements for the application are specified under "Registration".
- Abstract submitters were strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
General Guidelines
Abstracts should contain the following four components:
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the meeting and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the meeting and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.
Abstract Categories:
• Epidemiology of MASLD
• Economic and clinical burden of MASLD/MASH
• Non-Invasive Tests for MASLD/MASH
• Models of Care / Multidisciplinary Approaches
• Management: Lifestyle interventions and pharmacotherapeutics
• Diabetes and Cardiometabolic risk management in SLD
• Application of digital tools and artificial intelligence in SLD care
Abstract Categories:
• Epidemiology of MASLD
• Economic and clinical burden of MASLD/MASH
• Non-Invasive Tests for MASLD/MASH
• Models of Care / Multidisciplinary Approaches
• Management: Lifestyle interventions and pharmacotherapeutics
• Diabetes and Cardiometabolic risk management in SLD
• Application of digital tools and artificial intelligence in SLD care
Abstract Submission
Authors can submit their abstracts electronically until the deadline. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Poster Presentation Instructions for Face-to-Face Meeting
Posters need to meet the following dimensions: A0 size (approx 33" width x 47" height), portrait format
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Abstract Publication
Accepted abstracts will be published in the Abstract Book. This will be distributed during the meeting and will be available as enduring material after the meeting has concluded. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.
VE and AME is the sole copyright holder of the meeting abstract book as a whole. The abstract authors will retain any and all copyright over their individual abstracts. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
VE and AME is the sole copyright holder of the meeting abstract book as a whole. The abstract authors will retain any and all copyright over their individual abstracts. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Committees
Program Directors
Local Chair
Organizing Committee
Wilco Keulen, PhD
Scientific Program Coordinator, Academic Medical Education
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the think-tank, identify interesting topics and candidate speakers, and review all submitted abstracts.
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the think-tank as moderators and/or chairs of sessions.
Support
Financial backing helps us deliver an impactful think-tank experience for the benefit of healthcare professionals and community representatives involved in MASLD/MASH.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Brenda Evan at Brenda.Evan@amededu.com or call +31 30 230 7149
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgment on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the event bag
*Subject to the support level
Downloads:
Silver Level
Supporter
Friend Level
Media
Invitation to Join the Innovations in SLD Think-Tank 2024 | 3 - 4 May 2024
Invitation from Jeffrey Lazarus, PhD, MIH, MA, Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York and Jörn Schattenberg, MD, Saarland University Medical Center, Germany
Previous Editions
Partners
Media Partners
Endorsers
ZAGAN
Partners
If you would like your organization to support the Innovations in SLD Series as an endorser or media partner, please contact Brenda Evan at Brenda.Evan@amededu.com.
Language
Related Programs
